BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12207100)

  • 41. Estimates of peritoneal membrane function--new insights.
    Smit W
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii16-9. PubMed ID: 16825253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peritoneal dialysis: how to improve peritoneal permeability or function.
    Krediet RT; Ho-dac-Pannekeet M; Smit W; Zweers MM; Struijk DG
    Adv Nephrol Necker Hosp; 1997; 27():167-88. PubMed ID: 9408447
    [No Abstract]   [Full Text] [Related]  

  • 43. Peritoneal thickening is not inevitable in long-term peritoneal dialysis and is associated with peritoneal transport characteristics: a two-centre sonographic study.
    Lee TC; Yang JY; Wang HP; Tsai TJ; Yang Y
    Nephrol Dial Transplant; 2008 Mar; 23(3):1005-10. PubMed ID: 18042613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure.
    de Alvaro F; Castro MJ; Dapena F; Bajo MA; Fernandez-Reyes MJ; Romero JR; Jimenez C; Miranda B; Selgas R
    Adv Perit Dial; 1993; 9():56-61. PubMed ID: 8105963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Icodextrine peritoneal dialysis solution in clinical practice].
    Opatrná S
    Vnitr Lek; 2008 Dec; 54(12):1155-60. PubMed ID: 19140524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients.
    Davies SJ
    Kidney Int; 2004 Dec; 66(6):2437-45. PubMed ID: 15569337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peritoneal sclerosis--an overview.
    Garosi G; Di Paolo N
    Adv Perit Dial; 1999; 15():185-92. PubMed ID: 10682099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peritoneal inflammation and high transport status.
    Khanna R
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):167-9. PubMed ID: 17699204
    [No Abstract]   [Full Text] [Related]  

  • 49. Aquaporins are unlikely to be affected in marked ultrafiltration failure: results from a computer simulation.
    Rippe B; de Arteaga J; Venturoli D
    Perit Dial Int; 2001; 21 Suppl 3():S30-4. PubMed ID: 11887840
    [No Abstract]   [Full Text] [Related]  

  • 50. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.
    Cho JH; Hur IK; Kim CD; Park SH; Ryu HM; Yook JM; Choi JY; Choi HJ; Choi HJ; Park JW; Do JY; Kim YL
    Nephrol Dial Transplant; 2010 Jun; 25(6):1964-73. PubMed ID: 20100731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular mechanisms involved in the peritoneal membrane exposed to peritoneal dialysis.
    Devuyst O
    Nefrologia; 2003; 23 Suppl 3():32-7. PubMed ID: 12901190
    [No Abstract]   [Full Text] [Related]  

  • 52. Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.
    Verger C; Brunschvicg O; Le Charpentier Y; Lavergne A; Vantelon J
    Proc Eur Dial Transplant Assoc; 1981; 18():199-205. PubMed ID: 7329968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Water and solute transport across the peritoneal membrane.
    Morelle J; Devuyst O
    Curr Opin Nephrol Hypertens; 2015 Sep; 24(5):434-43. PubMed ID: 26197201
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time course of peritoneal transport parameters in peritoneal dialysis patients who develop peritoneal sclerosis.
    Sampimon DE; Coester AM; Struijk DG; Krediet RT
    Adv Perit Dial; 2007; 23():107-11. PubMed ID: 17886614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peritoneal Cell-free DNA: an innovative method for determining acute cell damage in peritoneal membrane and for monitoring the recovery process after peritonitis.
    Virzì GM; Milan Manani S; Brocca A; Cantaluppi V; de Cal M; Pastori S; Tantillo I; Zambon R; Crepaldi C; Ronco C
    J Nephrol; 2016 Feb; 29(1):111-8. PubMed ID: 26012380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simulations of osmotic ultrafiltration failure in CAPD using a serial three-pore membrane/fiber matrix model.
    Rippe B; Venturoli D
    Am J Physiol Renal Physiol; 2007 Mar; 292(3):F1035-43. PubMed ID: 17090782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathophysiology and morphological clinical correlation in experimental and peritoneal dialysis-induced peritoneal sclerosis.
    Garosi G; Di Paolo N
    Adv Perit Dial; 2000; 16():204-7. PubMed ID: 11045294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peritoneal sclerosis. A 'sword of Democles' for peritoneal dialysis?
    Schmidt RW; Blumenkrantz M
    Arch Intern Med; 1981 Sep; 141(10):1265-7. PubMed ID: 7271398
    [No Abstract]   [Full Text] [Related]  

  • 59. Diagnosis and management of encapsulating peritoneal sclerosis.
    Pollock CA
    Perit Dial Int; 2001; 21 Suppl 3():S61-6. PubMed ID: 11887865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of the size selectivity of peritoneal permeability by the restriction coefficient to protein transport.
    Krediet RT; Barreto DL; van Diepen AT
    Perit Dial Int; 2022 Jul; 42(4):335-343. PubMed ID: 35102776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.